Apotex chief executive officer and president, Jeremy Desai, has “resigned to pursue other opportunities”, with immediate effect. Jeff Watson – previously president of Global Generics – has been appointed as president and chief operating officer with responsibility for “day-to-day operations for the company on a global basis”, while vice-chairman Jack Kay will also assume the role of chief executive officer, having previously held the role before Desai’s appointment.
An Apotex spokesman told Generics bulletin that the firm would not “violate [our] commitment to privacy” by providing details surrounding...
